Bull World Health Organ. 1993;71(6):677-89.
This Memorandum reviews the results of research undertaken in animals and human subjects on once-a-month injectable contraceptives containing a progestogen and an estrogen, in particular the products Cyclofem and Mesigyna. Results from clinical trials, including effectiveness and side-effects, are evaluated and issues arising from health service research are discussed. The Memorandum concludes with a statement regarding the use of Cyclofem and Mesigyna as options for potential contraceptive users.
本备忘录回顾了在动物和人类受试者身上对含孕激素和雌激素的每月注射一次的避孕药进行的研究结果,特别是Cyclofem和Mesigyna产品。对包括有效性和副作用在内的临床试验结果进行了评估,并讨论了卫生服务研究中出现的问题。备忘录最后就Cyclofem和Mesigyna作为潜在避孕使用者的选择使用发表了声明。